CD4 and nasal cavity polyp: Ickrath et al. reported that CD4+ T cells from the nasal polyps of patients with ECRS exhibited a surface CD69 expression of 38.25% ± 14.23%; however, this expression was not detected in peripheral blood T cells [29].